Therapy News and Research

RSS

UTHealth Houston clinical trial therapy shrinks tumor of pancreatic cancer patient

Demetrios Stroubakis, 55, thought he was having a gallbladder attack when he arrived at the emergency room in August 2021 with jaundice. Instead, he was shocked to be diagnosed with pancreatic cancer.

13 Oct 2023

Rare ‘flesh-eating’ bacterium spreads North as oceans warm

Debbie King barely gave it a second thought when she scraped her right shin climbing onto her friend's pontoon for a day of boating in the Gulf of Mexico on Aug. 13.

13 Oct 2023

Are migraines linked to gut health and chronic non-communicable diseases?

The Links Between Migraines, Gut Health, and Chronic Non-Communicable Diseases (CNCDs).

13 Oct 2023

Cracking the code: recent discoveries transform our understanding of cancer-immunity cycle

In a recent review published in Immunity, researchers reviewed tumor-immunity cycle data.

13 Oct 2023

Ketogenic diets found to slash migraine frequency and fatigue in new study

Italian researchers find that ketogenic diets not only reduce the frequency and intensity of migraines but also significantly alleviate fatigue in sufferers. The study opens new doors for alternative, diet-based therapies for chronic and high-frequency episodic migraineurs.

12 Oct 2023

IL-17: The molecule that could revolutionize autoimmune and cancer treatments

The research paper explores the multifaceted role of the IL-17 family in immune response, covering everything from infection control to pathological conditions like autoimmune diseases and cancer. Future therapies may exploit IL-17's unique signaling pathways to offer more targeted and cost-effective treatments.

12 Oct 2023

Stroke experts map out path for better patient outcomes

Scientists from The Florey are among the world's leading stroke experts who have mapped out how researchers and clinicians can improve outcomes for people who have survived a stroke.

12 Oct 2023

Engineered bacteria deliver synthetic targets to solid tumors

For several years, researchers have been successfully using chimeric antigen receptor (CAR) T cells to target specific antigens found on blood cells as a cure for patients with leukemia and lymphoma.

12 Oct 2023

New AI-based method reduces latency in neurofeedback by 50-fold

Researchers from HSE University and the Artificial Intelligence Research Institute have successfully lowered the latency between a change in brain activity and the presentation of the corresponding neurofeedback signal by a factor of 50.

12 Oct 2023

New Alzheimer's study to combine drugs targeting amyloid and tau proteins

A new study will combine an Alzheimer's medication that slows disease progression in some patients with two other drugs to see if their effects can be amplified.

12 Oct 2023

Study reassures patients on safety of widely prescribed hypertension drug amlodipine

A new paper in the journal Function, published by Oxford Univetrsity Press, finds that a widely prescribed drug for treating hypertension, amlodipine, is not dangerous for patients, despite recent concerns from researchers and clinicians that taking amlodipine may have risks.

12 Oct 2023

TTUHSC receives nearly $2.3 million in CPRIT grants to support cancer research

The Cancer Prevention and Research Institute of Texas (CPRIT) recently awarded grants to four researchers from the Texas Tech University Health Sciences Center (TTUHSC).

12 Oct 2023

Study highlights ways to identify children at high risk of type 2 diabetes and prevention strategies

A new Journal of the Endocrine Society study highlights how to identify children at high risk of developing type 2 diabetes and strategies for prevention, such as anti-obesity or anti-diabetes medication and lifestyle changes.

12 Oct 2023

Cancer patients and oncologists support complementary therapies, but communication gap exists

Patients and oncologists are supportive of complementary therapies, such as nutrition counseling, exercise, massage, and mediation, for cancer treatment, according to a new survey conducted on behalf of the Healing Works Foundation.

12 Oct 2023

Does your gut microbiome play a role in therapeutic outcomes?

The role of the gut microbiome and its metabolites in altering the therapeutic outcomes

12 Oct 2023

Accelerating drug discovery with analytical R&D solutions

In this interview, Thermo Fisher Scientific discusses how to accelerate drug discovery through analytical R&D.

From Thermo Fisher Scientific – Pharmaceutical and Biopharmaceutical Solutions 12 Oct 2023

Large language models in medicine: Current limitations and future scope

The potential and limitations of artificial intelligence (AI)-based large language models (LLMs) in medical research.

12 Oct 2023

Is there an association between vitamin D deficiency and sepsis mortality?

The impact of deficient serum vitamin D levels on sepsis prognosis.

12 Oct 2023

Unlocking hope: Promising treatments for cognitive impairment in HIV patients on the horizon

Researchers examine the mechanisms responsible for the increased risk of neurocognitive impairment in HIV patients and explore potential treatments.

12 Oct 2023

OrganaBio launches new division to meet growing demand for decentralized clinical trial support

OrganaBio, the Contract Technology Development and Manufacturing Organization (CTDMO) specializing in solutions for cell and immunotherapy development, today announces the official launch of Cell Processing and Cryopreservation (CPC) Services, a new division of OrganaBio.

12 Oct 2023

Therapy News and Research

UTHealth Houston clinical trial therapy shrinks tumor of pancreatic cancer patient

Rare ‘flesh-eating’ bacterium spreads North as oceans warm

Are migraines linked to gut health and chronic non-communicable diseases?

Cracking the code: recent discoveries transform our understanding of cancer-immunity cycle

Ketogenic diets found to slash migraine frequency and fatigue in new study

IL-17: The molecule that could revolutionize autoimmune and cancer treatments

Stroke experts map out path for better patient outcomes

Engineered bacteria deliver synthetic targets to solid tumors

New AI-based method reduces latency in neurofeedback by 50-fold

New Alzheimer's study to combine drugs targeting amyloid and tau proteins

Study reassures patients on safety of widely prescribed hypertension drug amlodipine

TTUHSC receives nearly $2.3 million in CPRIT grants to support cancer research

Study highlights ways to identify children at high risk of type 2 diabetes and prevention strategies

Cancer patients and oncologists support complementary therapies, but communication gap exists

Does your gut microbiome play a role in therapeutic outcomes?

Accelerating drug discovery with analytical R&D solutions

Large language models in medicine: Current limitations and future scope

Is there an association between vitamin D deficiency and sepsis mortality?

Unlocking hope: Promising treatments for cognitive impairment in HIV patients on the horizon

OrganaBio launches new division to meet growing demand for decentralized clinical trial support

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News